title: [Metabolic and osteogenic pattern of prostate cancer bone metastases].
abstract: The current protocols include the bone scintigraphy and choline PET/CT to localize recurrence in patients having elevated serum PSA after treatment for prostate cancer. Both methods show good agreement in the diagnosis of bone metastases, however conflicting results can be found. We present three cases in which a PET/CT was performed with (18)F-Fluoride due to disagreement between the bone scintigraphy and (11)C-Choline PET/CT. The (18)F-Fluoride PET/CT was capable of confirming the existence of bone metastasis in all of them, so it may be an alternative to the MRI as a tracer of second bone imaging modality, although its use is limited by cost and availability.
authors: Unidad PET/TC, CETIR-ERESA, Esplugues de Llobregat, Barcelona, España. jrgarcia@cetir.es
authors: J R
authors: JR
authors: García
authors: E
authors: E
authors: Riera
authors: E
authors: E
authors: Valls
authors: M
authors: M
authors: Soler
authors: M
authors: M
authors: Moragas
authors: F
authors: F
authors: Lomeña
mesh_terms: D000368:Aged; D001859:Bone Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000556:secondary*; D002250:Carbon Radioisotopes; D002794:Choline; D005462:Fluorine Radioisotopes; D006801:Humans; D008297:Male; D064847:Multimodal Imaging; D010012:Osteogenesis; D049268:Positron-Emission Tomography; D011471:Prostatic Neoplasms / Q000473:pathology*; D014057:Tomography, X-Ray Computed
chemical_list: D002250:Carbon Radioisotopes; D005462:Fluorine Radioisotopes; D002794:Choline